Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

F-Labeled building blocks from the type of [F]fluorophenylazocarboxylic--butyl esters offer a rapid, mild, and reliable method for the F-fluoroarylation of biomolecules. Two series of azocarboxamides were synthesized as potential radioligands for dopamine D3 and the μ-opioid receptor, revealing compounds and with single-digit and sub-nanomolar affinity for the D3 receptor and compound with only micromolar affinity for the μ-opioid receptor, but enhanced selectivity for the μ-subtype in comparison to the lead compound AH-7921. A "minimalist procedure" without the use of a cryptand and base for the preparation of 4-[F]fluorophenylazocarboxylic--butyl ester was established, together with the radiosynthesis of methyl-, methoxy-, and phenyl-substituted derivatives (). With the substituted [F]fluorophenylazocarbylates in hand, two prototype azocarboxylates radioligands were synthesized by F-fluoroarylation, namely the methoxy azocarboxamide as the D3 receptor radioligand and as a prototype structure of the μ-opioid receptor radioligand. By introducing the new series of [F]fluorophenylazocarboxylic--butyl esters, the method of F-fluoroarylation was significantly expanded, thereby demonstrating the versatility of F-labeled phenylazocarboxylates for the design of potential radiotracers for positron emission tomography .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819854PMC
http://dx.doi.org/10.1021/acsomega.7b01374DOI Listing

Publication Analysis

Top Keywords

μ-opioid receptor
16
potential radioligands
8
radioligands dopamine
8
dopamine μ-opioid
8
[f]fluorophenylazocarboxylic--butyl esters
8
method f-fluoroarylation
8
receptor radioligand
8
receptor
6
[f]fluorophenylazocarboxylates design
4
design synthesis
4

Similar Publications

IGLV3-21-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.

Haematologica

September 2025

Division of Medical Oncology, University Hospital Basel, Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel.

We previously used a disease-specific B cell receptor (BCR) point mutation (IGLV3-21R110) for selective targeting of a high-risk subset of chronic lymphocytic leukemia (CLL) with chimeric antigen receptor (CAR) T cells. Since CLL is a disease of the elderly and a significant fraction of patients is not able to physically tolerate CAR T cell treatment, we explored bispecific antibodies as an alternative for precision targeting of this tumor mutation. Heterodimeric IgG1-based antibodies consisting of a fragment crystallizable region (Fc) attached to both an anti-IGLV3-21R110 Fab and an anti-CD3 (UCHT1) single chain variable fragment (R110-bsAb) selectively killed cell lines engineered to express high levels of the neoepitope as well as primary CLL cells using healthy donor and CLL patient-derived T cells as effectors.

View Article and Find Full Text PDF

Splenic erythrophagocytosis is regulated by ALX/FPR2 signaling.

Haematologica

September 2025

Center for Cardiometabolic Science, Christina Lee Brown Envirome Institute, Division of Environmental Medicine, Department of Medicine, University of Louisville, Louisville, Kentucky,.

Maintaining a healthy pool of circulating red blood cells (RBCs) is essential for adequate perfusion, as even minor changes in the population can impair oxygen delivery, resulting in serious health complications including tissue ischemia and organ dysfunction. This responsibility largely falls to specialized macrophages in the spleen, known as red pulp macrophages, which efficiently take up and recycle damaged RBCs. However, questions remain regarding how these macrophages are acutely activated to accommodate increased demand.

View Article and Find Full Text PDF

The estrogen receptor (ER or ERα) remains the primary therapeutic target for luminal breast cancer, with current treatments centered on competitive antagonists, receptor down-regulators, and aromatase inhibitors. Despite these options, resistance frequently emerges, highlighting the need for alternative targeting strategies. We discovered a novel mechanism of ER inhibition that targets the previously unexplored interface between the DNA-binding domain (DBD) and ligand-binding domain (LBD) of the receptor.

View Article and Find Full Text PDF

Objective: Postoperative hypothyroidism, a complication of thyroid lobectomy, occurs frequently. Unique cases of post-lobectomy painless thyroiditis, a pathology not previously reported, were recently observed in our practice. In this study, we aimed to retrospectively investigate the frequency and characteristics of thyroid dysfunction after lobectomy, focusing on painless thyroiditis.

View Article and Find Full Text PDF

PACAP versus CGRP in migraine: From mouse models to clinical translation.

Cephalalgia

September 2025

Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, USA.

Migraine is a complex neurological disorder involving multiple neuropeptides that modulate nociceptive and sensory pathways. The most studied peptide is calcitonin gene-related peptide (CGRP), which is a well-established migraine trigger and therapeutic target. Recently, another peptide, pituitary adenylate cyclase-activating polypeptide (PACAP), has emerged as an alternative target for migraine therapeutics.

View Article and Find Full Text PDF